VC Fund gives money back, says the market for mature startups is too weak

Related Stories

More Federal Workers Are Flooding the Job Market, with Worsening Prospects

AMC Says It Will Show More Ads Before Movies

A.I. Is Coming for the Coders Who Made It

Russian Intelligence Says It Collects WeChat Data. What Does That Mean?

Meta Is Creating a New A.I. Lab to Pursue 'Superintelligence'

Aurora, a foundation model for the Earth system

Disney and Universal Sue Midjourney for Copyright Infringement

Consumers Are Increasingly Turning To Buy-Now-Pay-Later Services For Groceries

Trump Taps Palantir to Compile Data on Americans

Do Patients Without a Terminal Illness Have the Right to Die?

Scientists Consider Leaving the U.S.

NYC Drivers Who Run Red Lights Get Tickets. E-Bike Riders Get Court Dates

The Gutting of America's Medical Research

Anthropic CEO Warns 'All Bets Are Off' in 10 Years, Opposes AI Regulation Moratorium

Balloons and Human Strength: How North Korea Righted a Toppled Warship

Doctors Were Preparing to Remove Their Organs. Then They Woke Up.

I'm Wirecutter's water-quality expert. I don't filter my water

Secret Russian Intelligence Document Shows Deep Suspicion of China

Trump to Send National Guard to L.A. To Quell Immigration Protests

'Welcome to Campus. Here's Your ChatGPT.'

Palantir’s Collection of Disease Data at C.D.C. Stirs Privacy Concerns

OpenAI, the firm that helped spark chatbot cheating, wants to embed A.I. in every facet of college.

We Saw Medicaid Work Requirements Up Close. You Don't Want This Chaos

China’s Chokehold on This Obscure Mineral Threatens the West’s Militaries

Kennedy Removes All CDC Vaccine Panel Experts

How Long Does It Take to Draw a Picture of Every Pub in London?

Fake Images and Conspiracy Theories Swirl Around L.A

F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’

This A.I

FDA to Use A.I. In Drug Approvals to 'Radically Increase Efficiency'